Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia

Mabrouk, Rafae El; Hussein, Dalia T; Abbas, Mohammed Ezz El Regal; Abdelmabood, Suzy

doi:10.1007/s00277-023-05210-9

Cited by 2 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…are in the range of 50-75 µg/kg, and close monitoring is recommended in Rh(D) positive patients to prevent secondary hemolytic anemia [16,17]. Finally, the promising results obtained with vitamin D supplementation in children with persistent and chronic ITP suggest that vitamin D may play an immunomodulatory role in ITP and, therefore, may be a therapeutic target [18].…”

Section: Before/after Splenectomymentioning

confidence: 99%

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Mingot-Castellano,

Canaro Hirnyk,

Sánchez-González

et al. 2023

JCM

View full text Add to dashboard Cite

Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.

show abstract

Section: Before/after Splenectomymentioning

confidence: 99%

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Mingot-Castellano,

Canaro Hirnyk,

Sánchez-González

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

Recommendations for the Clinical Approach to Primary Immune Thrombocytopenia

Mingot-Castellano,

Canaro Hirnyk,

Sánchez-González

et al. 2023

Preprint

View full text Add to dashboard Cite

Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to an increased destruction and a reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document which had been launched in 2011. The updated guidelines have been the reference for diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have properly updated the main recommendations. Our aim is to provide a practical tool to enable the integral management of all the aspects concerning primary ITP management.

show abstract

Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia

Cited by 2 publications

References 27 publications

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Recommendations for the Clinical Approach to Primary Immune Thrombocytopenia

Contact Info

Product

Resources

About